Articles

On September 15, 2011, GE and several financial partners announced a healthymagination open innovation challenge to discover ideas and create products that will assist in the fight against cancer, beginning specifically with breast cancer.

One effective way to manage the projected oncology workforce shortage is to increase the role of nurse practitioners and physician assistants in oncology practices, according to a new American Society of Clinical Oncology (ASCO) study, “Study of Collaborative Practice Arrangements” (SPCA), published September 15, 2011 in the Journal of Oncology Practice.

Golf balls may be small, but if struck by one, you would know that they have tremendous impact. So it was in the beginning of the Play for P.I.N.K. (PFP) organization when a small group of women proved to make a huge impact on funding for breast cancer research.

Thanks for taking the time to speak to us, Ernie. Can you tell us what motivated you to organize a P.I.N.K. event?

Ernie McCarren (EM): As a breast cancer survivor and as director of business development for MAMM, a magazine for women with breast cancer, I became keenly aware of the critical need for funding to support research to bring new and better therapies to market faster. By partnering with Play for P.I.N.K., we know that 100% of the funds that we raise will go directly to the Breast Cancer Research Foundation (BCRF).

Our research suggests that health education programs such as SHARE may have an important impact on improving bone health behaviors among adolescent survivors of childhood cancer,” lead author Darren Mays, PhD, MPH, Lombardi Comprehensive Cancer Center, tells the Academy of Oncology Nurse Navigators. Read More ›

Because cancer patients vary in their needs for cancer services, patients vary in the amount of navigation time they require. On a patient-by-patient basis, however, navigators congruously estimated the navigation intensity, and therefore the time requirement, that would be needed, reveals a first-of-its-kind study.

Results from an important phase 3 trial presented at the plenary session of the Annual Meeting of the American Society of Clinical Oncology (ASCO) could lead to prolonged treatment with adjuvant imatinib for gastrointestinal stromal tumors (GISTs).

The extension of imatinib treatment to 3 years, compared with the usual 1 year, resulted in a 54% reduced risk of recurrence and 55% reduced risk of death within 5 years for patients with high-risk disease, reported Heikki Joensuu, MD, of Helsinki University Central Hospital in Finland.

Chronic lymphocytic leukemia (CLL) is a neoplastic disease characterized by the accumulation of monoclonal lymphocytes in blood, bone marrow, and lymphoid tissue.¹ It is the most common form of leukemia in adults worldwide, with prevalence increasing with age. Read More ›

The setting is an 18th-century palace, Schloss Leopoldskron, and the adjoining Meierhof building. This is the home of the Salzburg Global Seminar, an international institution that challenges current and future leaders to develop creative ideas and innovative strategies for solving universal problems. Read More ›

The World Health Professions Alliance (WHPA) has produced an easy-to-use, practical guide to assist individuals and their health professionals diminish the risk of noncommunicable diseases (NCDs), which presently account for 60% of global deaths.¹ The WHPA Health Improvement Card consists of a health scorecard and includes “how to” guides for both individuals and health professionals.